Evobrutinib is an Orally Active BTK Inhibitor for Immunological Diseases Treatment
Bruton’s tyrosine kinase (BTK), a member of the Tec family of tyrosine kinases, is expressed in B cells, macrophages, and monocytes, but not in T cells. Mutations in the human…